COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR

COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR

The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CAMERON, John, KASIBHATLA, Shailaja, JIA, Yong, BILIC, Sanela, HOWARD, JR., Danny
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CAMERON, John
KASIBHATLA, Shailaja
JIA, Yong
BILIC, Sanela
HOWARD, JR., Danny
description The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PH12018500097A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PH12018500097A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PH12018500097A13</originalsourceid><addsrcrecordid>eNrjZDB19vd18vRzDPH091Pwd1MIcNE1VHD0C3F09_fzDA5RCPcM8QDyFVzd3YIUPP08PJ08Q_yDeBhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJfICHoZGBoYWpgYGBpbmjoTGRygCoiyh9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR</title><source>esp@cenet</source><creator>CAMERON, John ; KASIBHATLA, Shailaja ; JIA, Yong ; BILIC, Sanela ; HOWARD, JR., Danny</creator><creatorcontrib>CAMERON, John ; KASIBHATLA, Shailaja ; JIA, Yong ; BILIC, Sanela ; HOWARD, JR., Danny</creatorcontrib><description>The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180723&amp;DB=EPODOC&amp;CC=PH&amp;NR=12018500097A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180723&amp;DB=EPODOC&amp;CC=PH&amp;NR=12018500097A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAMERON, John</creatorcontrib><creatorcontrib>KASIBHATLA, Shailaja</creatorcontrib><creatorcontrib>JIA, Yong</creatorcontrib><creatorcontrib>BILIC, Sanela</creatorcontrib><creatorcontrib>HOWARD, JR., Danny</creatorcontrib><title>COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR</title><description>The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB19vd18vRzDPH091Pwd1MIcNE1VHD0C3F09_fzDA5RCPcM8QDyFVzd3YIUPP08PJ08Q_yDeBhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJfICHoZGBoYWpgYGBpbmjoTGRygCoiyh9</recordid><startdate>20180723</startdate><enddate>20180723</enddate><creator>CAMERON, John</creator><creator>KASIBHATLA, Shailaja</creator><creator>JIA, Yong</creator><creator>BILIC, Sanela</creator><creator>HOWARD, JR., Danny</creator><scope>EVB</scope></search><sort><creationdate>20180723</creationdate><title>COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR</title><author>CAMERON, John ; KASIBHATLA, Shailaja ; JIA, Yong ; BILIC, Sanela ; HOWARD, JR., Danny</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PH12018500097A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CAMERON, John</creatorcontrib><creatorcontrib>KASIBHATLA, Shailaja</creatorcontrib><creatorcontrib>JIA, Yong</creatorcontrib><creatorcontrib>BILIC, Sanela</creatorcontrib><creatorcontrib>HOWARD, JR., Danny</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAMERON, John</au><au>KASIBHATLA, Shailaja</au><au>JIA, Yong</au><au>BILIC, Sanela</au><au>HOWARD, JR., Danny</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR</title><date>2018-07-23</date><risdate>2018</risdate><abstract>The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_PH12018500097A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title COMBINATION OF PD-1 ANTAGONIST WITH AN EGFR INHIBITOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAMERON,%20John&rft.date=2018-07-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPH12018500097A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true